Hologic, Cytyc announce expiration of waiting period for merger

By Laura Lutz

Des Moines, July 3 - Hologic, Inc. and Cytyc Corp. said in a news release that one of the conditions for their merger has been satisfied with the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

The companies do not believe that the merger requires any more antitrust approvals, according to the release.

The deal is expected to close in the third quarter of 2007.

Hologic and Cytyc entered into a definitive agreement for the merger on May 20. Under the deal, Cytyc shareholder will receive 0.52 shares of Hologic common stock and $16.50 in cash for each share of Cytyc common stock. The total consideration will be about $6.2 billion.

Hologic is a diagnostic and medical imaging company based in Bedford, Mass. Cytyc is a medical device company based in Marlborough, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.